360 related articles for article (PubMed ID: 31158803)
1. Heamatococcus pluvialis ameliorates bone loss in experimentally-induced osteoporosis in rats via the regulation of OPG/RANKL pathway.
El-Baz FK; Saleh DO; Abdel Jaleel GA; Hussein RA; Hassan A
Biomed Pharmacother; 2019 Aug; 116():109017. PubMed ID: 31158803
[TBL] [Abstract][Full Text] [Related]
2. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
3. [Electroacupuncture Intervention Improves Cartilage Degeneration and Subchondral Bone Osteoporosis of Knee-joint Possibly by Adjusting OPG/RANK/RANKL Signaling in Ovariectomized Rats].
Sun GH; Liao Y; Liao Y; Ni ZY; Li N; Zhong PR; Li XH; Zhou J
Zhen Ci Yan Jiu; 2018 Dec; 43(12):781-7. PubMed ID: 30585456
[TBL] [Abstract][Full Text] [Related]
4. Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway.
Xu X; Tang Y; Lang Y; Liu Y; Cheng W; Xu H; Liu Y
Int J Nanomedicine; 2020; 15():9657-9668. PubMed ID: 33299310
[TBL] [Abstract][Full Text] [Related]
5. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
Hou JM; Xue Y; Lin QM
Acta Pharmacol Sin; 2012 Oct; 33(10):1277-84. PubMed ID: 22902986
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
7. Tetrandrine Attenuates Cartilage Degeneration, Osteoclast Proliferation, and Macrophage Transformation through Inhibiting P65 Phosphorylation in Ovariectomy-induced Osteoporosis.
Shi F; Ni L; Gao YM
Immunol Invest; 2022 Apr; 51(3):465-479. PubMed ID: 33140671
[TBL] [Abstract][Full Text] [Related]
8. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
9. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
Wang F; Zhang C; Ge W; Zhang G
J Cell Mol Med; 2019 Oct; 23(10):6744-6754. PubMed ID: 31402549
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling.
Ding Z; Shi H; Yang W
Pharmacology; 2019; 103(3-4):163-172. PubMed ID: 30695776
[TBL] [Abstract][Full Text] [Related]
12. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
Chen C; Zheng H; Qi S
Biol Trace Elem Res; 2019 Apr; 188(2):441-450. PubMed ID: 30014283
[TBL] [Abstract][Full Text] [Related]
13. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.
Ma B; Zhang Q; Wu D; Wang YL; Hu YY; Cheng YP; Yang ZD; Zheng YY; Ying HJ
Acta Pharmacol Sin; 2012 Apr; 33(4):479-89. PubMed ID: 22426695
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
15. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated
Tian Y; Chen J; Yan X; Ren D; Liu M; Zhang Q; Zhang Q; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):29-38. PubMed ID: 33176606
[TBL] [Abstract][Full Text] [Related]
16. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
Sheng ZF; Xu K; Ma YL; Liu JH; Dai RC; Zhang YH; Jiang YB; Liao EY
Osteoporos Int; 2009 Jan; 20(1):151-9. PubMed ID: 18496637
[TBL] [Abstract][Full Text] [Related]
17. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.
Zhang Y; Liu MW; He Y; Deng N; Chen Y; Huang J; Xie W
Int J Immunopathol Pharmacol; 2020; 34():2058738420941762. PubMed ID: 32674689
[TBL] [Abstract][Full Text] [Related]
19. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway.
Zhao Y; Wang HL; Li TT; Yang F; Tzeng CM
Drug Des Devel Ther; 2020; 14():195-206. PubMed ID: 32021104
[TBL] [Abstract][Full Text] [Related]
20. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
